Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
clinical specimen pediatric abridged>> Return to Rapid Reviews list.
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
clinical outcomes pediatric Abridged>> Return to Rapid Reviews list.
Emerging Infections
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
CP Abridged 29 Aug 2020 RGM
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
AsymptomaticPedia Abridged 04 Aug 2020 FCT
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
ECLIA 20200823_180625
Emerging Infections
For any questions or information, please email: covidrapidreviewteam@gmail.com.
RAgT_SR_22Aug2020_V4 Final
Rapid Review
For any questions or information, please email covidrapidreviewteam@gmail.com.
Facemask pedia Abridged 15June
Emerging Infections
For any questions or information, please email covidrapidreviewteam@gmail.com.
Steam Inhalation for COVID Full Report 14JUL2020 V1 TU MM SA EU LFD
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.